Omeros Corporation

Omeros Corporation is a biopharmaceutical company focused on developing and commercializing novel therapeutics for a wide range of diseases and disorders with significant unmet medical needs. They prioritize "first-in-class" drugs with novel mechanisms of action targeting previously untapped receptors and enzymes. The company's research technologies include a proprietary GPCR deorphanization system and a platform for discovering high-affinity monoclonal antibodies. They have multiple late- and early-stage assets in their pipeline, spanning various therapeutic areas, including complement-mediated disease, central nervous system disorders, and immuno-oncology.

Omeros operates with a collaborative and diverse team, driven by a commitment to scientific excellence and patient-centricity. They are headquartered in Seattle, Washington, and are publicly traded on NASDAQ under the ticker symbol OMER. Their commitment to innovative solutions and their deep understanding of the complex mechanisms underlying various diseases makes them a leading force in the biopharmaceutical industry.

Omeros offers a comprehensive benefits package to support the well-being of its employees and their families. This includes medical, dental, and vision insurance, a 401k retirement plan with an annual matching contribution, a flexible spending account, life and accidental death and dismemberment insurance, short- and long-term disability coverage, stock options, vacation time, sick time, paid holidays, and a commuter program.

Omeros Corporation is a biopharmaceutical company committed to developing and commercializing innovative, first-in-class therapies that address significant unmet medical needs. They focus on tackling challenging diseases and disorders, particularly in the areas of complement-mediated diseases, central nervous system disorders, and immuno-oncology. With a diverse and deep pipeline of small-molecule and protein therapeutics, Omeros aims to transform patient care by delivering life-saving therapies with new mechanisms of action that target previously untapped receptors and enzymes.

Omeros promotes a culture that values collaboration, creativity, and a shared passion for developing life-saving therapies. They emphasize the importance of a diverse team with unique abilities and experiences, all working together to achieve groundbreaking scientific advances. This commitment to innovation and teamwork creates a supportive and stimulating environment where employees feel empowered to contribute to the company's mission of improving patient outcomes.

Omeros Corporation values and fosters diversity, equity, and inclusion, believing that a diverse workforce with varied perspectives and experiences leads to stronger innovation and better outcomes. They strive to create an inclusive culture where everyone feels valued and respected, regardless of background, identity, or beliefs. This commitment is reflected in their recruitment practices, where they actively seek individuals from all corners of the globe, and their company structure, where they strategically build a diverse pipeline of first-in-class therapeutics to address a wide range of unmet medical needs.